Last reviewed · How we verify
Formoterol 12 mcg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Formoterol 12 mcg (Formoterol 12 mcg) — Boehringer Ingelheim.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Formoterol 12 mcg TARGET | Formoterol 12 mcg | Boehringer Ingelheim | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Formoterol 12 mcg CI watch — RSS
- Formoterol 12 mcg CI watch — Atom
- Formoterol 12 mcg CI watch — JSON
- Formoterol 12 mcg alone — RSS
Cite this brief
Drug Landscape (2026). Formoterol 12 mcg — Competitive Intelligence Brief. https://druglandscape.com/ci/formoterol-12-mcg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab